Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis

OBJECTIVE: To establish the incidence of demyelination in patients who have received anti–tumor necrosis factor alpha (anti-TNFα) therapy, through analysis of adverse events reported in a prospective cohort of patients receiving biological therapies. METHODS: A cohort study was performed on prospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Thomas R.P., Galloway, James, Davies, Rebecca, Hyrich, Kimme, Dobson, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105908/
https://www.ncbi.nlm.nih.gov/pubmed/33863839
http://dx.doi.org/10.1212/NXI.0000000000000992

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8105908/
https://www.ncbi.nlm.nih.gov/pubmed/33863839
http://dx.doi.org/10.1212/NXI.0000000000000992

Ejemplares similares